SCHEMBL6526406

SCHEMBL6526406

CCCCCCCCCCCCCCCCSCC(Nc1cnc(C)[nH]1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM6B O15054 3/20 0.40
KDM4A O75164 3/20 0.40
KDM4D Q6B0I6 3/20 0.40
KDM3B Q7LBC6 3/20 0.40
HIF1AN Q9NWT6 3/20 0.40
KDM5B Q9UGL1 3/20 0.40
KDM2A Q9Y2K7 3/20 0.40
GMNN O75496 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
CYP2C9 P11712 1/20 0.35
BLM P54132 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ICMT O60725 1/20 0.34
GPR84 Q9NQS5 3/20 0.34
PLA2G4B P0C869 3/20 0.33
CES2 O00748 1/20 0.33
SLC6A5 Q9Y345 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6526435 0.83 ICMT (0.38) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6523401 0.78 GMNN (0.36) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL12793162 0.78 FDPS (0.38) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6521996 0.77 KDM4E (0.41) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6520453 0.77 GMNN (0.40) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6524319 0.74 FDPS (0.42) MAPTCYP2C9SMN1; SMN2
SCHEMBL6518242 0.74 ICMT (0.38) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6527550 0.74 HCAR3 (0.38) KDM6BKDM4AKDM4DKDM3BHIF1AN
SCHEMBL6522607 0.74 KDM4E (0.46) TP53MAPTCYP2C9SMN1; SMN2
SCHEMBL6524718 0.73 ICMT (0.37) KDM6BKDM4AKDM4DKDM3BHIF1AN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE MPO, CYSLTR1, HNMT KDM6B 4310/4885KDM4A 2962/4885KDM4D 3611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.